Prism Johnson Limited has informed the Exchange about Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 Further investment in subsidiary company pursuant to Rights Issue.
PRSMJOHNSN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts less than Nifty Microcap 250 and 1.5 pts less than its Cement & Cement Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Prism Johnson Limited has invested approximately ₹25.51 crores in its subsidiary, Raheja QBE General Insurance Company Limited (RQBE), by subscribing to 1.68 crore equity shares offered on a rights basis. The shares were allotted at ₹10 each with a premium of ₹5.17 per share, and the allotment was completed on June 24, 2025. The company's shareholding percentage in RQBE remains unchanged, meaning this was done to maintain its existing stake rather than increase it. RQBE is a general insurance company offering services in health, motor, property, and liability segments, with turnover of ₹512 crores in FY25, up from ₹316 crores in FY24. The transaction is classified as a related party transaction but was conducted at arm's length, and no promoter group entities are involved.
This is a routine capital infusion to maintain the company's stake in its insurance subsidiary. The investment amount is modest relative to Prism Johnson's overall size and is unlikely to materially affect shareholders or the stock price. The growing turnover at RQBE (up 62% year-on-year) is a mildly positive indicator for the subsidiary's trajectory.